DOCSLIB.ORG

Open Moore Sarah P53network.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Open Moore Sarah P53network.Pdf THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY A SYSTEMATIC METHOD FOR ANALYZING STIMULUS-DEPENDENT ACTIVATION OF THE p53 TRANSCRIPTION NETWORK SARAH L. MOORE SPRING 2013 A thesis submitted in partial fulfillment of the requirements for a baccalaureate degree in Biochemistry and Molecular Biology with honors in Biochemistry and Molecular Biology Reviewed and approved* by the following: Dr. Yanming Wang Associate Professor of Biochemistry and Molecular Biology Thesis Supervisor Dr. Ming Tien Professor of Biochemistry and Molecular Biology Honors Advisor Dr. Scott Selleck Professor and Head, Department of Biochemistry and Molecular Biology * Signatures are on file in the Schreyer Honors College. i ABSTRACT The p53 protein responds to cellular stress, like DNA damage and nutrient depravation, by activating cell-cycle arrest, initiating apoptosis, or triggering autophagy (i.e., self eating). p53 also regulates a range of physiological functions, such as immune and inflammatory responses, metabolism, and cell motility. These diverse roles create the need for developing systematic methods to analyze which p53 pathways will be triggered or inhibited under certain conditions. To determine the expression patterns of p53 modifiers and target genes in response to various stresses, an extensive literature review was conducted to compile a quantitative reverse transcription polymerase chain reaction (qRT-PCR) primer library consisting of 350 genes involved in apoptosis, immune and inflammatory responses, metabolism, cell cycle control, autophagy, motility, DNA repair, and differentiation as part of the p53 network. Using this library, qRT-PCR was performed in cells with inducible p53 over-expression, DNA-damage, cancer drug treatment, serum starvation, and serum stimulation. Heat-map and statistical analyses of these data, organized by cellular pathways or chromosome locations, have yielded insight into the complex response of the p53 network. Ultimately, the expression patterns of these p53-related genes will provide knowledge of cellular decision making mechanisms and allow researchers to evaluate the effect of particular drugs on the p53 pathways. A compilation of this data and analysis can be found at: https://protected.personal.psu.edu/s/l/slm5430/zoombablue/Home.html ii TABLE OF CONTENTS List of Figures………………………………………………………………………………… iii List of Tables…………………………………………………………………………………. iv Acknowledgements…………………………………………………………………………… v Chapter 1: The p53 Network .………………………………………………………………… 1 1.1 - NFκB Immune and Inflammatory Responses ……………………………............... 1 1.2- Apoptosis ………………………………………………………………..………….. 3 1.3- Cell Structure and Motility ....…………………… ………………………................ 4 1.4- Autophagy ……………………………………………........................…………….. 4 1.5- Cell Growth and Proliferation ………………………………………….…………… 5 1.6- Metabolism and Oxidative Stress ………………………………………...………… 6 1.7- DNA Repair ………………………………………………………………………… 7 1.8- Differentiation ……………………………………………………………………… 8 1.9- Upstream Regulation ………………………………………….................................. 9 Chapter 2: Materials and Methods …………………………………………………………… 10 2.1- Gene Selection ……………………………………………………………………… 10 2.2- Primer Design ………………………………………………………………………. 10 2.3- Gene Mapping ………………………………………………………………………. 11 2.4- Cell Culturing and Drug Treatment ………………………………………………… 12 2.5- RNA Collection and Reverse Transcription ……………………………………….. 12 2.6- q-RT PCR ...………………………………………………………………………… 13 Chapter 3: Results ……………………………………………………………………………. 14 3.1- The Gene Set ………………………………………………………………………… 14 3.2- Direct p53 Over-expression …………………………………………………………. 14 3.3- Doxorubicin treatment ………………………………………………………………. 16 3.4- Serum Starvation ……………………………………………………………………. 18 3.5- Serum Stimulation ……………………………………………………………………20 3.6- Testing the cancer drug 6e ………………………………………………………….. 21 Chapter 4: Discussion ………………………………………………………………………… 23 References……………………………………………………………………………………. 49 iii List of Figures Figure 1- The p53 protein responds to a battery of cellular pathways in response to various upstream signals…………………………………………………………………… 24 Figure 2- qRT-PCR data from six treatment conditions reveals context-dependent impact on each of the p53 pathways……………………………………………………………….. 25 Figure 3- p53 over-expression results in pathway trends of activation or inhibition……… 26 Figure 4- Doxorubicin treatment affects the p53 network differently than direct p53 over- expression………………………………………………………………………………….. 27 Figure 5- Numerous NFκB functions are repressed by p53 over-expression but not Doxorubicin treatment……………………………………………………………………... 28 Figure 6: Serum Starvation affects cell metabolism……………………………………….. 29 Figure 7: Serum stimulation rescues starved cells…………………………………………. 30 Figure 8: Analysis of 6e drug treatment allows prediction of the drug mechanism of action……………………………………………………………………………………….. 31 iv List of Tables Table 1- The p53 gene library responds uniquely to different stimuli…………………….. 32 Table 2- qRT-PCR Primers………………………………………………………………… 41 v Acknowledgements I would like to thank Dr. Wang for all of the support, guidance, and great ideas he has provided in this endeavor. I would also like to thank the graduate students in the lab, Jing Hu, Shu Wang, Amy Chen, and Jinquan Sun for their support and assistance in learning lab protocols. This project was funded by a 2012 Undergraduate Summer Discovery Grant, the Eberly College of Science, and the Penn State Biochemistry Department Whitfield Award. 1 Chapter 1 The p53 Network The p53 protein, commonly referred to as “The Guardian of the Genome,” is a stress- activated tumor suppressor widely known to be one of the most commonly mutated genes in human cancer. As such, extensive research has been conducted to determine the role of the protein, which has revealed downstream targets implicated in numerous cell pathways, including the immune and inflammatory response, apoptosis, cell motility, autophagy, cell cycle arrest, metabolism and oxidative stress, DNA repair, and differentiation (Figure 1). Furthermore, numerous mechanisms that regulate p53 function have been identified, including ubiquitination by the MDM2 protein [1], phosphorylation by ATR [2], and methylation by the lysine methyltransferase Set9 [3]. Acetylation of the p53 protein by KAT5 has been shown to play a role in regulating whether p53 activation induces apoptosis or cell cycle arrest [4]. However, further understanding of the role of p53 in cell-fate decision making mechanisms is needed to develop therapeutic targets for cancer and disease treatment. Information regarding how specific p53 pathways, as well as individual genes within the pathways, are affected by particular cellular stresses will be useful for gaining further insight into p53 function, aid in drug testing and design, and may ultimately provide a starting point for determining genes involved in cross-talk between the pathways. 1.1: NFκB Immune and Inflammatory Response NFκB is a transcription factor constitutively present in the cytoplasm in an inactive form [5]. While there are seven NFκB-family proteins, the heterodimer comprised of p50 (encoded by NFκB1) and RELA is the most prevalent [6]. NFκB activation, triggered as part of an immune 2 response to viral particles and pathogen associated molecular patterns (PAMPs) such as lipopolysaccharide, results in migration of the transcription factor into the nucleus where it stimulates production of cytokines and chemokines central to inflammation [5]. This in turn results in propagation of the immune response. Beyond its role in the immune response, NFκB has been shown to regulate apoptosis, cell proliferation, and differentiation, all of which are also implicated in p53 function [6]. Correspondingly, the NFκB and p53 DNA binding sites are extremely similar, indicating that the two transcription factors may compete [7]. NFκB has also been shown to induce p53 expression. Furthermore, increased p53 expression in a Tet-On Saos2 p53-inducible cell line results in NFκB activation, and this activation is necessary for p53-induced apoptosis [8]. However, NFκB has been implicated in both anti-apoptotic and pro-apoptotic pathways. While promoting p53- induced apoptosis, for example, NFκB inhibits TNFα-mediated cell death, despite the fact that TNFα is one of the primary activators of NFκB. In addition to a clear connection between p53 and NFκB itself, numerous genes within the NFκB immune and inflammatory pathway have also been shown to affect or be affected by p53. For example, the cytokine CCL2 has been shown to be activated by ultraviolet-radiation (UV)-induced p53 [9]. However, it is not clear if this response is consistent when p53 is activated by other stresses. TRAIL (TNFα-related apoptosis-inducing ligand) is a p53 target gene which contributes to apoptosis [10]. It is also, as its name suggests, capable of inducing apoptosis via TNFα independent of p53. Furthermore, TRAIL activation of NFκB has been identified as a mechanism for cell protection [11], possibly reflecting NFκB-mediated inhibition of TNFα- induced apoptosis. Because it is both a pro-apoptotic molecule and NFκB activator in certain 3 contexts, with conflicting results, further analysis of this gene in the context of various stresses is needed to gain an understanding of its role in these pathways. 1.2: Apoptosis The role of the p53 protein in inducing apoptosis, or programmed cell death, has long been known as one of the primary mechanisms for tumor suppression.
Load more

Recommended publications
  • DNA Damage Triggers Tubular Endoplasmic Reticulum Extension to Promote Apoptosis by Facilitating ER-Mitochondria Signaling
    www.nature.com/cr www.cell-research.com ARTICLE OPEN DNA damage triggers tubular endoplasmic reticulum extension to promote apoptosis by facilitating ER-mitochondria signaling Pengli Zheng1,2, Qingzhou Chen1, Xiaoyu Tian1, Nannan Qian1,3, Peiyuan Chai1, Bing Liu1,4, Junjie Hu 5,6, Craig Blackstone2, Desheng Zhu7, Junlin Teng 1 and Jianguo Chen1,4 The endoplasmic reticulum (ER) is composed of the nuclear envelope, perinuclear sheets and a peripheral tubular network. The peripheral ER and mitochondria form tight contacts at specific subdomains, which coordinate the functions of the two organelles and are required for multiple cellular processes such as Ca2+ transfer and apoptosis. However, it is largely unknown how ER morphology and ER-mitochondria signaling are dynamically regulated under different physiological or pathological conditions such as DNA damage. Here we show that the peripheral, tubular ER undergoes significant extension in response to DNA damage, and that this process is dependent on p53-mediated transcriptional activation of the ER-shaping proteins REEP1, REEP2 and EI24 (alias PIG8). This promotes the formation of ER-mitochondria contacts through EI24 and the mitochondrial outer membrane protein VDAC2, facilitates Ca2+ transfer from ER to mitochondria and promotes DNA damage-induced apoptosis. Thus, we identify a unique DNA damage response pathway involving alterations in ER morphology, ER-mitochondria signaling, and apoptosis. Cell Research (2018) 28:833–854; https://doi.org/10.1038/s41422-018-0065-z INTRODUCTION transfer with high efficiency from the ER to mitochondria, which The endoplasmic reticulum (ER) is the largest membranous is necessary for mitochondrial metabolism.16 However, dramati- organelle and performs essential roles in protein synthesis and cally increased ER-mitochondria Ca2+ flux triggers apoptosis by secretion, Ca2+ homeostasis, and lipid metabolism.
    [Show full text]
  • Anti-ATG9B Antibody (ARG59749)
    Product datasheet [email protected] ARG59749 Package: 50 μg anti-ATG9B antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes ATG9B Tested Reactivity Hu Predict Reactivity Ms, Rat Tested Application ICC/IF, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name ATG9B Antigen Species Human Immunogen A 17 amino acid peptide within aa. 850 - 900 of Human ATG9B. Conjugation Un-conjugated Alternate Names APG9-like 2; SONE; NOS3AS; Autophagy-related protein 9B; Protein sONE; APG9L2; Nitric oxide synthase 3-overlapping antisense gene protein Application Instructions Application table Application Dilution ICC/IF 10 - 20 µg/ml WB 1 - 2 µg/ml Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control HeLa Calculated Mw 101 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer PBS and 0.02% Sodium azide Preservative 0.02% Sodium azide Concentration 1 mg/ml Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. www.arigobio.com 1/3 Note For laboratory research only, not for drug, diagnostic or other use. Bioinformation Gene Symbol ATG9B Gene Full Name autophagy related 9B Background This gene functions in the regulation of autophagy, a lysosomal degradation pathway. This gene also functions as an antisense transcript in the posttranscriptional regulation of the endothelial nitric oxide synthase 3 gene, which has 3' overlap with this gene on the opposite strand.
    [Show full text]
  • Ei24) Reduced Cell Proliferation and Aggregate-Size in Dictyostelium Discoideum NEHA GUPTA and SHWETA SARAN*
    Int. J. Dev. Biol. 62: 273-283 (2018) https://doi.org/10.1387/ijdb.170327ss www.intjdevbiol.com Deletion of etoposide-induced 2.4 kb transcript (ei24) reduced cell proliferation and aggregate-size in Dictyostelium discoideum NEHA GUPTA and SHWETA SARAN* School of Life Sciences, Jawaharlal Nehru University, New Delhi, India ABSTRACT The etoposide-induced 2.4 kb transcript (ei24) gene is induced both by p53 and etoposide, an anti-cancer tumour drug. There is no p53 gene present in Dictyostelium discoideum. Thus, the functions of ei24 in the absence of p53 were analysed. Both overexpressor (ei24OE) and knockout (ei24-) mutants were made to study its role during growth, development and differentiation. Addi- tionally, cell cycle and its response to DNA-damage were also analysed. We identified, characterized and elucidated the functions of the ei24 gene in Dictyostelium. In silico analyses demonstrated the conservation across eukaryotes and in situ hybridization showed it to be prestalk-specific.ei24 - cells showed reduced cell proliferation and cell-cohesive properties, ultimately forming small-sized ag- gregates that developed into miniature and stalky fruiting bodies. The ei24OE cells formed fruiting bodies with engorged or double-decker type sori with short stalks. The ei24- cells showed reduced cAMP signalling with lower intracellular cAMP levels resulting in diminished migration of cells along cAMP gradients. Deletion of ei24 resulted in mis-expression of prestalk-specific markers. Cell cycle analysis revealed an increased bias towards the stalk-pathway by ei24- cells and vice-versa for ei24OE cells. EI24 in Dictyostelium functions even in the absence of p53 and is induced in response to both UV-radiation and etoposide treatments.
    [Show full text]
  • Chromosomal Aberrations in Head and Neck Squamous Cell Carcinomas in Norwegian and Sudanese Populations by Array Comparative Genomic Hybridization
    825-843 12/9/08 15:31 Page 825 ONCOLOGY REPORTS 20: 825-843, 2008 825 Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization ERIC ROMAN1,2, LEONARDO A. MEZA-ZEPEDA3, STINE H. KRESSE3, OLA MYKLEBOST3,4, ENDRE N. VASSTRAND2 and SALAH O. IBRAHIM1,2 1Department of Biomedicine, Faculty of Medicine and Dentistry, University of Bergen, Jonas Lies vei 91; 2Department of Oral Sciences - Periodontology, Faculty of Medicine and Dentistry, University of Bergen, Årstadveien 17, 5009 Bergen; 3Department of Tumor Biology, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Center, Montebello, 0310 Oslo; 4Department of Molecular Biosciences, University of Oslo, Blindernveien 31, 0371 Oslo, Norway Received January 30, 2008; Accepted April 29, 2008 DOI: 10.3892/or_00000080 Abstract. We used microarray-based comparative genomic logical parameters showed little correlation, suggesting an hybridization to explore genome-wide profiles of chromosomal occurrence of gains/losses regardless of ethnic differences and aberrations in 26 samples of head and neck cancers compared clinicopathological status between the patients from the two to their pair-wise normal controls. The samples were obtained countries. Our findings indicate the existence of common from Sudanese (n=11) and Norwegian (n=15) patients. The gene-specific amplifications/deletions in these tumors, findings were correlated with clinicopathological variables. regardless of the source of the samples or attributed We identified the amplification of 41 common chromosomal carcinogenic risk factors. regions (harboring 149 candidate genes) and the deletion of 22 (28 candidate genes). Predominant chromosomal alterations Introduction that were observed included high-level amplification at 1q21 (harboring the S100A gene family) and 11q22 (including Head and neck squamous cell carcinoma (HNSCC), including several MMP family members).
    [Show full text]
  • Seq2pathway Vignette
    seq2pathway Vignette Bin Wang, Xinan Holly Yang, Arjun Kinstlick May 19, 2021 Contents 1 Abstract 1 2 Package Installation 2 3 runseq2pathway 2 4 Two main functions 3 4.1 seq2gene . .3 4.1.1 seq2gene flowchart . .3 4.1.2 runseq2gene inputs/parameters . .5 4.1.3 runseq2gene outputs . .8 4.2 gene2pathway . 10 4.2.1 gene2pathway flowchart . 11 4.2.2 gene2pathway test inputs/parameters . 11 4.2.3 gene2pathway test outputs . 12 5 Examples 13 5.1 ChIP-seq data analysis . 13 5.1.1 Map ChIP-seq enriched peaks to genes using runseq2gene .................... 13 5.1.2 Discover enriched GO terms using gene2pathway_test with gene scores . 15 5.1.3 Discover enriched GO terms using Fisher's Exact test without gene scores . 17 5.1.4 Add description for genes . 20 5.2 RNA-seq data analysis . 20 6 R environment session 23 1 Abstract Seq2pathway is a novel computational tool to analyze functional gene-sets (including signaling pathways) using variable next-generation sequencing data[1]. Integral to this tool are the \seq2gene" and \gene2pathway" components in series that infer a quantitative pathway-level profile for each sample. The seq2gene function assigns phenotype-associated significance of genomic regions to gene-level scores, where the significance could be p-values of SNPs or point mutations, protein-binding affinity, or transcriptional expression level. The seq2gene function has the feasibility to assign non-exon regions to a range of neighboring genes besides the nearest one, thus facilitating the study of functional non-coding elements[2]. Then the gene2pathway summarizes gene-level measurements to pathway-level scores, comparing the quantity of significance for gene members within a pathway with those outside a pathway.
    [Show full text]
  • Genome-Wide Approach to Identify Risk Factors for Therapy-Related Myeloid Leukemia
    Leukemia (2006) 20, 239–246 & 2006 Nature Publishing Group All rights reserved 0887-6924/06 $30.00 www.nature.com/leu ORIGINAL ARTICLE Genome-wide approach to identify risk factors for therapy-related myeloid leukemia A Bogni1, C Cheng2, W Liu2, W Yang1, J Pfeffer1, S Mukatira3, D French1, JR Downing4, C-H Pui4,5,6 and MV Relling1,6 1Department of Pharmaceutical Sciences, The University of Tennessee, Memphis, TN, USA; 2Department of Biostatistics, The University of Tennessee, Memphis, TN, USA; 3Hartwell Center, The University of Tennessee, Memphis, TN, USA; 4Department of Pathology, The University of Tennessee, Memphis, TN, USA; 5Department of Hematology/Oncology St Jude Children’s Research Hospital, The University of Tennessee, Memphis, TN, USA; and 6Colleges of Medicine and Pharmacy, The University of Tennessee, Memphis, TN, USA Using a target gene approach, only a few host genetic risk therapy increases, the importance of identifying host factors for factors for treatment-related myeloid leukemia (t-ML) have been secondary neoplasms increases. defined. Gene expression microarrays allow for a more 4 genome-wide approach to assess possible genetic risk factors Because DNA microarrays interrogate multiple ( 10 000) for t-ML. We assessed gene expression profiles (n ¼ 12 625 genes in one experiment, they allow for a ‘genome-wide’ probe sets) in diagnostic acute lymphoblastic leukemic cells assessment of genes that may predispose to leukemogenesis. from 228 children treated on protocols that included leukemo- DNA microarray analysis of gene expression has been used to genic agents such as etoposide, 13 of whom developed t-ML. identify distinct expression profiles that are characteristic of Expression of 68 probes, corresponding to 63 genes, was different leukemia subtypes.13,14 Studies using this method have significantly related to risk of t-ML.
    [Show full text]
  • Wnt/Β-Catenin Signaling Pathway Induces Autophagy
    Yun et al. Cell Death and Disease (2020) 11:771 https://doi.org/10.1038/s41419-020-02988-8 Cell Death & Disease ARTICLE Open Access Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma Eun-Jin Yun 1,SangwooKim2,Jer-TsongHsieh3,4 and Seung Tae Baek 5,6 Abstract Temozolomide (TMZ) is widely used for treating glioblastoma multiforme (GBM), however, the treatment of such brain tumors remains a challenge due to the development of resistance. Increasing studies have found that TMZ treatment could induce autophagy that may link to therapeutic resistance in GBM, but, the precise mechanisms are not fully understood. Understanding the molecular mechanisms underlying the response of GBM to chemotherapy is paramount for developing improved cancer therapeutics. In this study, we demonstrated that the loss of DOC-2/DAB2 interacting protein (DAB2IP) is responsible for TMZ-resistance in GBM through ATG9B. DAB2IP sensitized GBM to TMZ and suppressed TMZ-induced autophagy by negatively regulating ATG9B expression. A higher level of ATG9B expression was associated with GBM compared to low-grade glioma. The knockdown of ATG9B expression in GBM cells suppressed TMZ-induced autophagy as well as TMZ-resistance. Furthermore, we showed that DAB2IP negatively regulated ATG9B expression by blocking the Wnt/β-catenin pathway. To enhance the benefit of TMZ and avoid therapeutic resistance, effective combination strategies were tested using a small molecule inhibitor blocking the Wnt/ β-catenin pathway in addition to TMZ. The combination treatment synergistically enhanced the efficacy of TMZ in GBM cells. In conclusion, the present study identified the mechanisms of TMZ-resistance of GBM mediated by DAB2IP 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; and ATG9B which provides insight into a potential strategy to overcome TMZ chemo-resistance.
    [Show full text]
  • Location Analysis of Estrogen Receptor Target Promoters Reveals That
    Location analysis of estrogen receptor ␣ target promoters reveals that FOXA1 defines a domain of the estrogen response Jose´ e Laganie` re*†, Genevie` ve Deblois*, Ce´ line Lefebvre*, Alain R. Bataille‡, Franc¸ois Robert‡, and Vincent Gigue` re*†§ *Molecular Oncology Group, Departments of Medicine and Oncology, McGill University Health Centre, Montreal, QC, Canada H3A 1A1; †Department of Biochemistry, McGill University, Montreal, QC, Canada H3G 1Y6; and ‡Laboratory of Chromatin and Genomic Expression, Institut de Recherches Cliniques de Montre´al, Montreal, QC, Canada H2W 1R7 Communicated by Ronald M. Evans, The Salk Institute for Biological Studies, La Jolla, CA, July 1, 2005 (received for review June 3, 2005) Nuclear receptors can activate diverse biological pathways within general absence of large scale functional data linking these putative a target cell in response to their cognate ligands, but how this binding sites with gene expression in specific cell types. compartmentalization is achieved at the level of gene regulation is Recently, chromatin immunoprecipitation (ChIP) has been used poorly understood. We used a genome-wide analysis of promoter in combination with promoter or genomic DNA microarrays to occupancy by the estrogen receptor ␣ (ER␣) in MCF-7 cells to identify loci recognized by transcription factors in a genome-wide investigate the molecular mechanisms underlying the action of manner in mammalian cells (20–24). This technology, termed 17␤-estradiol (E2) in controlling the growth of breast cancer cells. ChIP-on-chip or location analysis, can therefore be used to deter- We identified 153 promoters bound by ER␣ in the presence of E2. mine the global gene expression program that characterize the Motif-finding algorithms demonstrated that the estrogen re- action of a nuclear receptor in response to its natural ligand.
    [Show full text]
  • Novel Insights Into Autophagy from Multicellular Model Systems
    Feature Review Eaten alive: novel insights into autophagy from multicellular model systems 1 2 Hong Zhang and Eric H. Baehrecke 1 Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China 2 Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA Autophagy delivers cytoplasmic material to lysosomes are essential for autophagosome formation [7,8]. Remark- for degradation. First identified in yeast, the core genes ably, the core autophagy machinery that is encoded by that control this process are conserved in higher organ- these genes is conserved between yeast and humans isms. Studies of mammalian cell cultures have expanded [6]. Many studies of immortalized mammalian cell lines our understanding of the core autophagy pathway, but indicate that, as in yeast, nutrient-limiting conditions cannot reveal the unique animal-specific mechanisms induce autophagy that is dependent on ATG genes. How- for the regulation and function of autophagy. Multicel- ever, several aspects of the autophagy pathway in higher lular organisms have different types of cells that possess eukaryotes are distinct from that in yeast. In yeast, all distinct composition, morphology, and organization of autophagosomes arise from the single perivacuolar preau- intracellular organelles. In addition, the autophagic ma- tophagosomal structure (PAS). In higher eukaryotes, there chinery integrates signals from other cells and environ- is no evidence for a PAS and isolation membranes can be mental conditions to maintain cell, tissue and organism generated simultaneously at multiple sites, implicating homeostasis. Here, we highlight how studies of autop- more complex sources for autophagosomal membranes. hagy in flies and worms have identified novel core Indeed, the endoplasmic reticulum (ER), mitochondria, autophagy genes and mechanisms, and provided insight plasma membrane, and recycling endosomes have been into the context-specific regulation and function of shown to contribute to autophagosomal membranes autophagy.
    [Show full text]
  • A Genomic Approach to Study Down Syndrome and Cancer Inverse Comorbidity: Untangling the Chromosome 21
    PERSPECTIVE ARTICLE published: 04 February 2015 doi: 10.3389/fphys.2015.00010 A genomic approach to study down syndrome and cancer inverse comorbidity: untangling the chromosome 21 Jaume Forés-Martos , Raimundo Cervera-Vidal , Enrique Chirivella , Alberto Ramos-Jarero and Joan Climent* Genomics and Systems Biology (InGSB) Lab, Oncology and Hematology Department, Biomedical Research Institute INCLIVA, Valencia, Spain Edited by: Down syndrome (DS), one of the most common birth defects and the most widespread Anaïs Baudot, Centre National de la genetic cause of intellectual disabilities, is caused by extra genetic material on Recherche Scientifique, France chromosome 21 (HSA21). The increased genomic dosage of trisomy 21 is thought to Reviewed by: be responsible for the distinct DS phenotypes, including an increased risk of developing Cristian Bellodi, Lund University, Sweden some types of childhood leukemia and germ cell tumors. Patients with DS, however, have Jian-Hua Mao, Lawrence Berkeley a strikingly lower incidence of many other solid tumors. We hypothesized that the third National Laboratory, USA copy of genes located in HSA21 may have an important role on the protective effect *Correspondence: that DS patients show against most types of solid tumors. Focusing on Copy Number Joan Climent, Genomics and Variation (CNV) array data, we have generated frequencies of deleted regions in HSA21 in Systems Biology (InGSB) Lab, Oncology and Hematology four different tumor types from which DS patients have been reported to be protected. Department, Biomedical Research We describe three different regions of deletion pointing to a set of candidate genes Institute INCLIVA, Avda Blasco that could explain the inverse comorbidity phenomenon between DS and solid tumors.
    [Show full text]
  • BTG2: a Rising Star of Tumor Suppressors (Review)
    INTERNATIONAL JOURNAL OF ONCOLOGY 46: 459-464, 2015 BTG2: A rising star of tumor suppressors (Review) BIjING MAO1, ZHIMIN ZHANG1,2 and GE WANG1 1Cancer Center, Institute of Surgical Research, Daping Hospital, Third Military Medical University, Chongqing 400042; 2Department of Oncology, Wuhan General Hospital of Guangzhou Command, People's Liberation Army, Wuhan, Hubei 430070, P.R. China Received September 22, 2014; Accepted November 3, 2014 DOI: 10.3892/ijo.2014.2765 Abstract. B-cell translocation gene 2 (BTG2), the first 1. Discovery of BTG2 in TOB/BTG gene family gene identified in the BTG/TOB gene family, is involved in many biological activities in cancer cells acting as a tumor The TOB/BTG genes belong to the anti-proliferative gene suppressor. The BTG2 expression is downregulated in many family that includes six different genes in vertebrates: TOB1, human cancers. It is an instantaneous early response gene and TOB2, BTG1 BTG2/TIS21/PC3, BTG3 and BTG4 (Fig. 1). plays important roles in cell differentiation, proliferation, DNA The conserved domain of BTG N-terminal contains two damage repair, and apoptosis in cancer cells. Moreover, BTG2 regions, named box A and box B, which show a high level of is regulated by many factors involving different signal path- homology to the other domains (1-5). Box A has a major effect ways. However, the regulatory mechanism of BTG2 is largely on cell proliferation, while box B plays a role in combination unknown. Recently, the relationship between microRNAs and with many target molecules. Compared with other family BTG2 has attracted much attention. MicroRNA-21 (miR-21) members, BTG1 and BTG2 have an additional region named has been found to regulate BTG2 gene during carcinogenesis.
    [Show full text]
  • Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3Rd Edition)
    AUTOPHAGY 2016, VOL. 12, NO. 1, 1–222 http://dx.doi.org/10.1080/15548627.2015.1100356 EDITORIAL Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J Klionsky1745,1749*, Kotb Abdelmohsen840, Akihisa Abe1237, Md Joynal Abedin1762, Hagai Abeliovich425, Abraham Acevedo Arozena789, Hiroaki Adachi1800, Christopher M Adams1669, Peter D Adams57, Khosrow Adeli1981, Peter J Adhihetty1625, Sharon G Adler700, Galila Agam67, Rajesh Agarwal1587, Manish K Aghi1537, Maria Agnello1826, Patrizia Agostinis664, Patricia V Aguilar1960, Julio Aguirre-Ghiso784,786, Edoardo M Airoldi89,422, Slimane Ait-Si-Ali1376, Takahiko Akematsu2010, Emmanuel T Akporiaye1097, Mohamed Al-Rubeai1394, Guillermo M Albaiceta1294, Chris Albanese363, Diego Albani561, Matthew L Albert517, Jesus Aldudo128, Hana Algul€ 1164, Mehrdad Alirezaei1198, Iraide Alloza642,888, Alexandru Almasan206, Maylin Almonte-Beceril524, Emad S Alnemri1212, Covadonga Alonso544, Nihal Altan-Bonnet848, Dario C Altieri1205, Silvia Alvarez1497, Lydia Alvarez-Erviti1395, Sandro Alves107, Giuseppina Amadoro860, Atsuo Amano930, Consuelo Amantini1554, Santiago Ambrosio1458, Ivano Amelio756, Amal O Amer918, Mohamed Amessou2089, Angelika Amon726, Zhenyi An1538, Frank A Anania291, Stig U Andersen6, Usha P Andley2079, Catherine K Andreadi1690, Nathalie Andrieu-Abadie502, Alberto Anel2027, David K Ann58, Shailendra Anoopkumar-Dukie388, Manuela Antonioli832,858, Hiroshi Aoki1791, Nadezda Apostolova2007, Saveria Aquila1500, Katia Aquilano1876, Koichi Araki292, Eli Arama2098,
    [Show full text]